Skip to content

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Jul 1, 2026

Data as of Oct 16

▼ SELL$26.7K100 shares at $267.19Solomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.
Watch NTRA
Traded
Jul 1, 2026
Disclosed
Jul 6, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Jul 1, 2026TRADEDDISCLOSED
NTRASimilar stocks (XLV — its sector index fund), rebased to NTRA's price on the disclosure day
NTRA since disclosure
+38.6%
after the sale
Similar stocks (XLV) since disclosure
+9.1%
XLV — its sector index fund

Change in closing price from Jul 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$710Kdisclosed Jul 6 · filed 5 days after the trade · late
  2. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$82.2Kdisclosed Jul 6 · filed 5 days after the trade · late

See every trade on NTRA →